Clinical Pharmacy for Patients With a PICC Line
- Conditions
- Catheter Complications
- Interventions
- Other: Clinical pharmacy activities along the care pathways
- Registration Number
- NCT04359056
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
Clinical pharmacy is a patient-centered discipline and improves significantly the safety of drug management. Regarding medications, clinical pharmacy is efficient. The investigator hypothesize that clinical pharmacy applied to medical devices could be as effective as in the medication field.
The main objective of this study is to assess the effectiveness of clinical pharmacy activities during entire care pathways of patients implanted with a PICC line, in preventing complications.
- Detailed Description
This is a preliminary, before-after, monocentric and prospective study. The study will begin with an observational period and will be followed by an experimental intervention period. Sixty-nine adult patients in each period will be included. During the observational phase, no clinical pharmacy activities will be performed. During the interventional phase, clinical pharmacists will be active during the entire patients' care pathways.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 138
- Adult patient, age equal to or older than 18 years old
- Patient capable of giving free and informed consent
- Patient insured by the Social Security System
- Patient living at home
- Patient with a PICC line prescription
- Patient whose discharge prescription should contain drugs and MDs
- Patient for home discharge implanted with a PICC line
- Patient reachable by phone
- Under aged patient, age under 18 years old
- Uninsured patient by the Social Security System
- Patient not living at home :
- Institutionalized patient
- Patient living in a home for elderly dependent persons
- Nursing home resident
- Home-hospitalized patient
- Patient deprived of liberty by a judicial or administrative decision
- Patient under guardianship, curatorship or safeguard of justice
- Patient unreachable by phone
- Pregnant or breastfeeding women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Interventional Clinical pharmacy activities along the care pathways patients for the interventional phase where clinical pharmacy activities will be performed at each step of the care pathway: from hospitalization to home care.
- Primary Outcome Measures
Name Time Method Assessment of the number of complications during the interventional phase. 3 months Number of complications per patient and per month in each group. Number of complications per patient and per month in each group
- Secondary Outcome Measures
Name Time Method Number of consultations and rehospitalizations post-discharge. 3 months Rates of consultations and rehospitalizations in each group.
Conformity analysis of the PICC line logistic circuit day 0 Number of correct items over total (items checklist about stock, supply chain, traceability)
Conformity analysis of hospital prescriptions issued in town. day 0 Conformity rates per phase.
healthcare professionals satisfaction survey 3 months assessment of healthcare professionals' satisfactions regarding their collaboration with the pharmacists
Conformity analysis of treatment indication. day 0 Number of correct items over total (items checklist about recommended indications, implantation duration, etc.)
Direct hospital costs. 3 months description and evaluation of the direct medical costs
Participants satisfaction survey 3 months Assessment of patients' satisfactions regarding their therapeutic management
Acceptance rate of pharmaceutical interventions (PI) during interventional phase and evaluation of PIs' criticality. 3 months Number of potentially inappropriate prescriptions resulting in an accepted PI over total of PIs.
Patient's Quality Of Life assessment 3 months EQ-5D-5L score
Trial Locations
- Locations (1)
CIVADE
🇫🇷Toulouse, Occitanie, France